PDF herunterladen
CC BY 4.0 · Rev Bras Ginecol Obstet 2020; 42(08): 501-507
DOI: 10.1055/s-0040-1712131
Review Article

Primary Dysmenorrhea: Assessment and Treatment

Dismenorreia primária: Avaliação e tratamento
Inês Guimarães 
1   Faculty of Medicine, Universidade do Porto, Porto, Portugal
,
Ana Margarida Póvoa 
1   Faculty of Medicine, Universidade do Porto, Porto, Portugal
2   Department of Gynecology, Unit of Reproductive Medicine, Centro Hospitalar Universitário de São João, Porto, Portugal
› Institutsangaben
› Weitere Informationen
   Lizenzen und Reprints

Abstract

Primary dysmenorrhea is defined as menstrual pain in the absence of pelvic disease. It is characterized by overproduction of prostaglandins by the endometrium, causing uterine hypercontractility that results in uterine muscle ischemia, hypoxia, and, subsequently, pain. It is the most common gynecological illness in women in their reproductive years and one of the most frequent causes of pelvic pain; however, it is underdiagnosed, undertreated, and even undervalued by women themselves, who accept it as part of the menstrual cycle. It has major implications for quality of life, such as limitation of daily activities and psychological stress, being one of the main causes of school and work absenteeism. Its diagnosis is essentially clinical, based on the clinical history and normal physical examination. It is important to exclude secondary causes of dysmenorrhea. The treatment may have different approaches (pharmacological, non-pharmacological and surgical), but the first line of treatment is the use of nonsteroidal anti-inflammatory drugs (NSAIDs), and, in cases of women who want contraception, the use of hormonal contraceptives. Alternative treatments, such as topical heat, lifestyle modification, transcutaneous electrical nerve stimulation, dietary supplements, acupuncture, and acupressure, may be an option in cases of conventional treatments' contraindication. Surgical treatment is only indicated in rare cases of women with severe dysmenorrhea refractory to treatment.

Resumo

Dismenorreia primária é definida como dor menstrual na ausência de patologia pélvica. Caracteriza-se pelo excesso de produção de prostaglandinas pelo endométrio que provocam hipercontractilidade uterina, resultando em isquemia e hipoxia do músculo uterino e, subsequentemente, dor. É a patologia ginecológica mais comum em mulheres em idade fértil e uma das causas mais frequentes de dor pélvica; contudo, é subdiagnosticada, subtratada, e até desvalorizada pelas próprias mulheres, que a aceitam como parte do ciclo menstrual. A dismenorreia tem grandes implicações na qualidade de vida, como limitação das atividades diárias e estresse psicológico, sendo uma das principais causas de absentismo escolar e laboral. O seu diagnóstico é essencialmente clínico, baseando-se na história clínica e num exame físico sem alterações. É importante excluir causas secundárias de dismenorreia. O tratamento pode ter diferentes abordagens (farmacológica, não farmacológica e cirúrgica), sendo que a primeira linha de tratamento consiste na utilização de anti-inflamatórios não esteroides (AINEs) e, em casos de mulheres que desejem contracepção, no uso de anticoncepcionais hormonais. Tratamentos alternativos, como a utilização de calor tópico, modificação do estilo de vida, estimulação elétrica nervosa transcutânea, suplementos alimentares, acupuntura e acupressão, podem ser uma opção nos casos de contraindicação da utilização dos tratamentos convencionais. O tratamento cirúrgico apenas se encontra indicado em casos raros de mulheres com dismenorreia grave e refratária aos tratamentos.

Keywords

dysmenorrhea - menstrual cycle - pain - NSAIDs - hormonal contraception

Palavras-chave

dismenorreia - ciclo menstrual - dor - AINEs - contracepção hormonal


Publikationsverlauf

Eingereicht: 09. Dezember 2019

Angenommen: 23. März 2020

Artikel online veröffentlicht:
19. Juni 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Thieme Revinter Publicações Ltda
Rio de Janeiro, Brazil

 

  • References

  • 1 Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update 2015; 21 (06) 762-778 . Doi: 10.1093/humupd/dmv039
    CrossrefPubMedSuche in Google Scholar
  • 2 Burnett M, Lemyre M. No. 345-primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can 2017; 39 (07) 585-595 . Doi: 10.1016/j.jogc.2016.12.023
    CrossrefPubMedSuche in Google Scholar
  • 3 Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol 2006; 108 (02) 428-441 . Doi: 10.1097/01.AOG.0000230214.26638.0c
    CrossrefPubMedSuche in Google Scholar
  • 4 Osayande AS, Mehulic S. Diagnosis and initial management of dysmenorrhea. Am Fam Physician 2014; 89 (05) 341-346
    PubMedSuche in Google Scholar
  • 5 Doty E, Attaran M. Managing primary dysmenorrhea. J Pediatr Adolesc Gynecol 2006; 19 (05) 341-344 . Doi: 10.1016/j.jpag.2006.06.005
    CrossrefPubMedSuche in Google Scholar
  • 6 ACOG Committee Opinion No. 760: dysmenorrhea and endometriosis in the adolescent. Obstet Gynecol 2018; 132 (06) e249-e258 . Doi: 10.1097/AOG.0000000000002978
    CrossrefPubMedSuche in Google Scholar
  • 7 French L. Dysmenorrhea. Am Fam Physician 2005; 71 (02) 285-291
    PubMedSuche in Google Scholar
  • 8 Harel Z. Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies. Expert Opin Pharmacother 2012; 13 (15) 2157-2170 . Doi: 10.1517/14656566.2012.725045
    CrossrefPubMedSuche in Google Scholar
  • 9 Morrow C, Naumburg EH. Dysmenorrhea. Prim Care 2009; 36 (01) 19-32, vii . Doi: 10.1016/j.pop.2008.10.004
    CrossrefPubMedSuche in Google Scholar
  • 10 Latthe P, Latthe M, Say L, Gülmezoglu M, Khan KS. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health 2006; 6: 177 . Doi: 10.1186/1471-2458-6-177
    CrossrefPubMedSuche in Google Scholar
  • 11 Zahradnik HP, Hanjalic-Beck A, Groth K. Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a review. Contraception 2010; 81 (03) 185-196 . Doi: 10.1016/j.contraception.2009.09.014
    CrossrefPubMedSuche in Google Scholar
  • 12 Rodrigues AC, Gala S, Neves Â, Pinto C, Meirelles C, Frutuoso C, Vítor ME. Dismenorreia em adolescentes e jovens adultas: prevalência, factores associados e limitações na vida diária. Acta Med Port 2011; 24 (Suppl. 02) 383-388 , quiz 389–392
    PubMedSuche in Google Scholar
  • 13 National Sleep Foundation [Internet]. Women and sleep poll. 1998 [cited 2019 Jul 18]. Available from: https://www.sleepfoundation.org/articles/women-and-sleep
    PubMedSuche in Google Scholar
  • 14 French L. Dysmenorrhea in adolescents: diagnosis and treatment. Paediatr Drugs 2008; 10 (01) 1-7 . Doi: 10.2165/00148581-200810010-00001
    CrossrefPubMedSuche in Google Scholar
  • 15 Ryan SA. The treatment of dysmenorrhea. Pediatr Clin North Am 2017; 64 (02) 331-342 . Doi: 10.1016/j.pcl.2016.11.004
    CrossrefPubMedSuche in Google Scholar
  • 16 Granot M, Yarnitsky D, Itskovitz-Eldor J, Granovsky Y, Peer E, Zimmer EZ. Pain perception in women with dysmenorrhea. Obstet Gynecol 2001; 98 (03) 407-411 . Doi: 10.1016/s0029-7844(01)01465-x
    PubMedSuche in Google Scholar
  • 17 Bajaj P, Bajaj P, Madsen H, Arendt-Nielsen L. A comparison of modality-specific somatosensory changes during menstruation in dysmenorrheic and nondysmenorrheic women. Clin J Pain 2002; 18 (03) 180-190 . Doi: 10.1097/00002508-200205000-00007
    CrossrefPubMedSuche in Google Scholar
  • 18 Tu CH, Niddam DM, Chao HT, Chen LF, Chen YS, Wu YT. , et al. Brain morphological changes associated with cyclic menstrual pain. Pain 2010; 150 (03) 462-468 . Doi: 10.1016/j.pain.2010.05.026
    CrossrefPubMedSuche in Google Scholar
  • 19 Yu A. Complementary and alternative treatments for primary dysmenorrhea in adolescents. Nurse Pract 2014; 39 (11) 1-12 . Doi: 10.1097/01.NPR.0000454984.19413.28
    CrossrefPubMedSuche in Google Scholar
  • 20 Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev 2014; 36: 104-113 . Doi: 10.1093/epirev/mxt009
    CrossrefPubMedSuche in Google Scholar
  • 21 Xu K, Chen L, Fu L. , et al. Stressful parental-bonding exaggerates the functional and emotional disturbances of primary dysmenorrhea. Int J Behav Med 2016; 23 (04) 458-463 . Doi: 10.1007/s12529-015-9504-0
    CrossrefPubMedSuche in Google Scholar
  • 22 Chen CX, Kwekkeboom KL, Ward SE. Self-report pain and symptom measures for primary dysmenorrhoea: a critical review. Eur J Pain 2015; 19 (03) 377-391 . Doi: 10.1002/ejp.556
    CrossrefPubMedSuche in Google Scholar
  • 23 Smith RP, Kaunitz AM. Dysmenorrhea in adult women: treatment [Internet]. 2019 [cited 2019 Mar 10]. Available from: https://www.uptodate.com/contents/dysmenorrhea-in-adult-women-treatment
    PubMedSuche in Google Scholar
  • 24 Harel Z. Cyclooxygenase-2 specific inhibitors in the treatment of dysmenorrhea. J Pediatr Adolesc Gynecol 2004; 17 (02) 75-79 . Doi: 10.1016/j.jpag.2004.01.002
    CrossrefPubMedSuche in Google Scholar
  • 25 Trussell J. Contraceptive failure in the United States. Contraception 2011; 83 (05) 397-404 . Doi: 10.1016/j.contraception.2011.01.021
    CrossrefPubMedSuche in Google Scholar
  • 26 Roumen FJ. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials. Contraception 2007; 75 (06) 420-429 . Doi: 10.1016/j.contraception.2007.01.013
    CrossrefPubMedSuche in Google Scholar
  • 27 Morgan PJ, Kung R, Tarshis J. Nitroglycerin as a uterine relaxant: a systematic review. J Obstet Gynaecol Can 2002; 24 (05) 403-409 . Doi: 10.1016/s1701-2163(16)30403-0
    CrossrefPubMedSuche in Google Scholar
  • 28 Andersson KE, Ulmsten U. Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhoea. Br J Obstet Gynaecol 1978; 85 (02) 142-148 . Doi: 10.1111/j.1471-0528.1978.tb10469.x
    CrossrefPubMedSuche in Google Scholar
  • 29 Armour M, Ee CC, Naidoo D, Ayati Z, Chalmers KJ, Steel KA. , et al. Exercise for dysmenorrhoea. Cochrane Database Syst Rev 2019; 9: CD004142 . Doi: 10.1002/14651858.CD004142.pub4
    PubMedSuche in Google Scholar
  • 30 Pattanittum P, Kunyanone N, Brown J, Sangkomkamhang US, Barnes J, Seyfoddin V, Marjoribanks J. Dietary supplements for dysmenorrhoea. Cochrane Database Syst Rev 2016; 3: CD002124 . Doi: 10.1002/14651858.CD002124.pub2
    PubMedSuche in Google Scholar
  • 31 Zhang F, Sun M, Han S, Shen X, Luo Y, Zhong D. , et al. Acupuncture for primary dysmenorrhea: an overview of systematic reviews. Evid Based Complement Alternat Med 2018; 2018: 8791538 . Doi: 10.1155/2018/8791538
    CrossrefPubMedSuche in Google Scholar
  • 32 Smith CA, Armour M, Zhu X, Li X, Lu ZY, Song J. Acupuncture for dysmenorrhoea. Cochrane Database Syst Rev 2016; 4: CD007854 . Doi: 10.1002/14651858.CD007854.pub3
    PubMedSuche in Google Scholar
  • 33 Ramirez C, Donnellan N. Pelvic denervation procedures for dysmenorrhea. Curr Opin Obstet Gynecol 2017; 29 (04) 225-230 . Doi: 10.1097/GCO.0000000000000379
    CrossrefPubMedSuche in Google Scholar